GSM2265465 |
SAMPLE 4_Healthy control-derived iPS cells (HC-4)_2 |
GSM2265466 |
SAMPLE 5_SCD162-17-2-derived iPS cells_1 |
GSM2265467 |
SAMPLE 6_SCD162-17-2-derived iPS cells_2 |
GSM2265468 |
SAMPLE 7_SCD16-2E-derived iPS cells_1 |
GSM2265469 |
SAMPLE 8_SCD16-2E-derived iPS cells_2 |
GSM2265470 |
SAMPLE 9_Healthy control-derived iPS cells (201B7)_1 |
GSM2265471 |
SAMPLE 10_Healthy control-derived iPS cells (201B7)_2 |
GSM2265472 |
SAMPLE 11_SCD166-2-14-derived iPS cells_1 |
GSM2265473 |
SAMPLE 12_SCD166-2-14-derived iPS cells_2 |
GSM2265474 |
SAMPLE 13_Normal human dermal fibroblasts |
GSM2265475 |
Day35 Control-derived neural progenitor cells 1 |
GSM2265476 |
Day35 Control-derived neural progenitor cells 2 |
GSM2265477 |
Day35 Control-derived neural progenitor cells 3 |
GSM2265478 |
Day35 Control-derived neural progenitor cells 4 |
GSM2265479 |
Day35 Case-derived neural progenitor cells 1 |
GSM2265480 |
Day35 Case-derived neural progenitor cells 2 |
GSM2265481 |
Day35 Case-derived neural progenitor cells 3 |
GSM2265482 |
Day35 Case-derived neural progenitor cells 4 |